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Abstract
 
Intracellular parasites are known to persist lifelong in mammalian hosts after the clinical cure of
the disease, but the mechanisms of persistence are poorly understood. Here, we show by con-
focal laser microscopy that in the draining lymph nodes of mice that had healed a cutaneous in-
 
fection with 
 
Leishmania major
 
, 40% of the persisting parasites were associated with fibroblasts
forming the reticular meshwork of the lymph nodes. In vitro, both promastigotes and amasti-
 
gotes of 
 
L
 
.
 
 major
 
 infected primary skin or lymph node fibroblasts. Compared with macrophages,
cytokine-activated fibroblasts had a reduced ability to express type 2 nitric oxide synthase and
to kill intracellular 
 
L
 
.
 
 major
 
. These data identify fibroblasts as an important host cell for 
 
Leish-
mania
 
 during the chronic phase of infection and suggest that they might serve as safe targets for
the parasites in clinically latent disease.
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Introduction
 
A hallmark of infections with certain viruses (e.g., herpes-
viruses), intracellular bacteria (e.g., 
 
Mycobacteria
 
, 
 
Coxiella
 
,
 
Chlamydiae
 
), or protozoa (e.g., 
 
Trypanosoma cruzi
 
, 
 
Leishmania
 
)
is the long-term persistence of the pathogen after clinical
cure of the disease. Based on in vitro results, modulation of
host cell antimicrobial activities, synthesis of inhibitory cy-
 
tokines, impairment of T cell activation, or retreat of the
pathogen into cells that do not elicit an immune response
have been proposed as viral or microbial survival strategies,
but the mechanisms of persistence in vivo remain ill de-
fined (1, 2). One example are infections with 
 
Leishmania
 
parasites. 
 
Leishmania 
 
promastigotes are transmitted by sand
flies to mammalian hosts, where they infect macrophages,
granulocytes, and dendritic cells, transform into amasti-
gotes, and cause cutaneous, mucocutaneous, or progressive
visceral disease. In most strains of mice as well as in hu-
mans, infections with 
 
Leishmania major
 
 usually elicit skin
swellings or single ulcers that are ultimately controlled by a
 
CD4
 
1
 
 T cell response involving the production of IFN-
 
g
 
and the activation of antileishmanial effector mechanisms in
macrophages (3–6). In mice, IFN-
 
a
 
/
 
b
 
 and IFN-
 
g
 
 induced
 
the production of nitric oxide (NO)
 
1
 
 by the inducible (or
type 2) NO synthase (iNOS or NOS2), which was shown
to be indispensable for the healing of acute cutaneous le-
sions (7–10).
After spontaneous or chemotherapy-mediated healing of
the infection, both mice and humans continue to harbor
small numbers of alive
 
 Leishmania
 
 parasites in the lymphoid
tissue (11–13). This was demonstrated most convincingly
by the recrudescence of the disease after treatment with
immunosuppressive drugs, depletion of CD4
 
1
 
 T cells, or
inhibition of NOS2 activity (14–17). Although the compo-
nents of the immune system that are responsible for the res-
olution of acute 
 
Leishmania
 
 infection are well defined, little
is known about the mechanisms that allow the parasites to
survive lifelong in the host. In genetically resistant mice
that had resolved a skin infection with 
 
L
 
.
 
 major
 
, we found
that NOS2 activity was indispensable for the long-term
control of the remaining parasites. 30–40% of the parasites
persisting in the draining lymph node colocalized with
NOS2-positive macrophages or dendritic cells, whereas
60–70% of the parasites were located in NOS2-negative ar-
eas that could not be stained with known markers for mac-
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rophages, dendritic cells, granulocytes, or endothelial cells
and thus remained undefined (17). As fibroblasts had been
reported to be susceptible to infection with various 
 
Leish-
mania
 
 species in vitro (18–20), and lymph nodes from
chronically infected mice contained strongly increased
amounts of fibrous tissue, we considered the possibility that
 
Leishmania
 
 might also reside in fibroblasts in vivo. In this
study, we identify reticular fibroblasts in lymph nodes as
major host cells for 
 
L
 
.
 
 major
 
 during latent disease and pro-
vide evidence that these cells might function as “safe tar-
gets” (21) for the parasites.
 
Materials and Methods
 
Parasites.
 
The 
 
L
 
.
 
 major
 
 strain MHOM/IL/81/FE/BNI (17)
was propagated in vitro in RPMI 1640 plus 10% FCS on Novy-
Nicolle-MacNeal blood agar slants for a maximum of six passages.
Fresh 
 
L
 
.
 
 major
 
 promastigotes were derived from amastigotes that
were isolated from the ulcerated skin lesions or the spleens of
BALB/c mice as described (22).
 
Mice.
 
Female C57BL/6 mice, weighing 16–18 g, were pur-
chased from Charles River, housed in our own facilities, and used
at 8–12 wk of age.
 
   
 
C57BL/6 mice were inoculated into the right
hind footpad with 3 
 
3
 
 10
 
6
 
 stationary phase 
 
L
 
.
 
 major
 
 promasti-
gotes. In some experiments, mice were infected bilaterally into
both hind footpads. The footpad swelling was measured with a
metric caliper. The mice resolved their skin lesions usually within
60–70 d after infection. For immunohistological analyses, the
popliteal lymph nodes draining the site of infection were re-
moved from mice that had been infected for at least 100 d.
 
Macrophages.
 
Thioglycollate-elicited peritoneal exudate mac-
rophages (PEMs) were prepared from the peritoneal cavity of
C57BL/6 mice as described (23). Resident peritoneal macro-
phages (RPMs) were obtained from C57BL/6 mice by flushing
the peritoneal cavity twice with 10 ml ice-cold PBS. The cells
were resuspended in RPMI 1640 culture medium (supplemented
as described [23] plus 1 or 2.5% fetal bovine serum [Sigma-
Aldrich]), seeded into 24-well plates (10
 
6
 
 cells/well in 500 
 
m
 
l) or
8-well LabTek
 
®
 
 chamber slides (Permanox
 
®
 
; Nalge Nunc Inter-
national), and cultured at 37
 
8
 
C in 5% CO
 
2
 
/95% humidified air.
After 90–120 min, nonadherent cells were washed off and the
macrophage monolayers were further incubated as indicated.
 
Isolation of Fibroblasts.
 
Murine skin fibroblasts were estab-
lished from ear skin explants of C57BL/6 mice as described (24).
In brief, after removal of the epidermis, the dermis was cut into 1 
 
3
 
2 mm pieces, which then were allowed to attach to tissue culture
petri dishes before addition of complete RPMI 1640 medium
(see above) supplemented with 10–20% FCS. Nonadherent cells
were removed by weekly medium exchanges. After 2–4 wk, fi-
broblasts grew out from the explants that were passaged after
treatment with 0.25% trypsin-EDTA solution and further propa-
gated in RPMI 1640 supplemented with 5% FCS by weekly 1:3
splitting.
Reticular fibroblasts were obtained from popliteal lymph
nodes (
 
z
 
30–90 mg) of chronically infected mice (
 
.
 
200 d after
infection with
 
 L
 
.
 
 major
 
). Collagenase D (100 U/ml in PBS; Boeh-
ringer) was injected into the lymph nodes that had been carefully
prepared and freed of extracapsular tissue. The lymph nodes were
opened and the cell suspension was harvested in PBS with 100
U/ml collagenase D. Finally, the lymph nodes were teased into
small fragments that were further digested in PBS plus 400 U/ml
 
collagenase D at 37
 
8
 
C for 60–90 min. Undigested (capsular) frag-
ments were removed and the cells were pooled with the primary
suspension, centrifuged, washed, and seeded in small tissue cul-
ture flasks (Nalge Nunc International) in RPMI 1640 medium
plus 10–20% FCS. Nonadherent cells were removed by weekly
medium exchanges. After 2–4 wk, fibroblasts were growing in
the cultures.
For infection or phenotypic characterization, skin or lymph
node fibroblasts were harvested with a rubber policeman, seeded,
and used as confluent monolayers. To minimize growth, the se-
rum concentration was reduced to 1–2.5%.
 
Infection of Macrophages and Fibroblasts with L. major Parasites.
 
Monolayers of macrophages or fibroblasts in 24-well plates were
incubated with a 3–10-fold excess of 
 
L
 
.
 
 major
 
 promastigotes or
amastigotes, either continuously (permanent infection) or for
4–14 h after which nonphagocytosed parasites were washed off
(pulse infection). The cells were activated with recombinant mu-
rine (rm)IFN-
 
g
 
 (provided by Dr. G. Adolf, Ernst Boehringer In-
stitut, Vienna, Austria) with or without rmTNF-
 
a
 
 (R&D Sys-
tems) or LPS (
 
Escherichia coli
 
 O111:B; Sigma-Aldrich). Culture
medium was replaced every 24 h.
The infection rate and the number of intracellular parasites per
infected cell were determined by immunoenzymatic or immu-
nofluorescence staining of the monolayers. At least 300 cells were
evaluated. The total number of intracellular parasites per culture
was determined by two different methods that were previously
shown to yield comparable results (22). In brief, infected mac-
rophage or fibroblast monolayers were lysed in SDS (0.01% in se-
rum-free RPMI) to release intracellular parasites. After addition
of a twofold volume of modified Schneider’s 
 
Drosophila
 
 medium
(mSDM) (25), the cell lysates were spun and the pellets contain-
ing the amastigotes were resuspended in 500 
 
m
 
l modified
mSDM. The parasite suspensions were seeded in triplicates into
96-well flat-bottomed plates for further incubation (24–48 h) and
pulsed with 1 
 
m
 
Ci (37 kBq)/well of [
 
3
 
H]desoxy-thymidine (25
Ci/mmol; Amersham Pharmacia Biotech) for the last 12–18 h.
Alternatively, the parasite suspensions were subjected to limiting
dilution analysis using serial 2-fold dilutions and 12–24 individual
wells per dilution step. After 7 d of culture, the number of wells
negative for parasites was determined for each dilution and the
number of viable 
 
L
 
.
 
 major
 
 parasites per culture condition was cal-
culated by applying Poisson statistics and the 
 
x
 
2
 
 minimization
method (8, 22).
 
Cocultures of Macrophages and Fibroblasts.
 
PEMs were allowed
to adhere (2 h) to the outer side of the membrane (pore size 0.45
 
m
 
M) of cell culture insets (Costar). The insets were then im-
merged in culture wells containing complete RPMI 1640 me-
dium with 2.5% FCS. Reticular fibroblasts were added and, after
adherence to the inner side of the membrane (6 h), were pulse-
infected with 
 
L
 
.
 
 major
 
 amastigotes (ratio 4–10:1) for 12 h. There-
after, the insets were transferred to new wells containing culture
medium with or without stimuli (see also Fig. 3 D).
 
Determination of Nitrite.
 
As an indirect measurement for the
production of NO, culture supernatants were analyzed for their
content of nitrite (NO
 
2
 
2
 
) using the Griess reaction (23).
 
Transmission Electron Microscopy.
 
Incubation of fibroblasts with
 
L
 
.
 
 major
 
 parasites was stopped by adding an excess amount of cold
Ito’s fixative to the cells (26). After overnight fixation at 4
 
8
 
C, the
samples were further processed according to established protocols
(27). In brief, washes with 0.1 M cacodylate buffer, pH 7.4, were
followed by postfixation in ferricyanide-reduced 1% osmium
tetroxide, washes with 0.9% saline solution, encapsulation in 2%
agar, en bloc staining with an alcoholic mixture of 0.5% phospho- 
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tungstic acid and 0.25% uranyl acetate, physical dehydration with
a graded series of ethanolic solutions ending with pure acetone,
and embedding in Epon 812 resin. Ultrathin sections were placed
onto 200-mesh standard square copper grids, stained with a mix-
ture of 10% uranyl acetate and 2.8% lead citrate, and viewed with
a Zeiss type 906 transmission electron microscope.
 
Antibody Reagents.
 
Rabbit antisera against human fibronectin,
human laminin-1, human collagen VI (recombinant N9-N2 do-
main), mouse fibulin-2, or mouse perlecan (recombinant III-3 do-
main) were as described (28–31). The human or rabbit antiserum
against 
 
L
 
.
 
 major
 
, the rabbit antiserum against mouse NOS2 pep-
tide, the rat mAbs against macrophages (Mac-1, F4/80, BM-8,
MOMA-2, and ER-MP-23), granulocytes (GR-1), dendritic cells
(NLDC-145), or endothelial cells (MECA-32) were the same as
used previously (17). The rat mAbs M5/114.15.2 (32) and ER-
TR7 (33) were used for the detection of MHC class II antigens
and mouse reticular fibroblasts, respectively. All rat mAbs as well
as all of the secondary antibodies (affinity-purified biotin-conju-
gated donkey anti–rabbit IgG, mouse anti–rat IgG or goat anti–
human IgG F[ab
 
9
 
]
 
2
 
 fragments; affinity-purified Cy5- or lissamine
rhodamine sulfochloride [LRSC]-conjugated donkey anti–rabbit
IgG, Cy5- or dichlorotriazinyl aminofluorescein [DTAF]-conju-
gated donkey anti–rat IgG, or DTAF-conjugated goat anti–human
IgG F[ab
 
9
 
]
 
2
 
 fragments) were purchased from Dianova.
 
Immunoenzymatic Staining of Frozen Tissue Sections and of Fibro-
blasts and Macrophages.
 
5–6-
 
m
 
M tissue sections from embedded
lymph nodes were prepared with a cryostat microtome (model
HM 500 OM; Fa. Microm International GmbH), thawed onto
slides coated with Fro-Marker
 
®
 
 (Science Services), surrounded
with PAP PEN
 
®
 
 (Science Services), air-dried, fixed in acetone
(for 10 min, at 
 
2
 
20
 
8
 
C), and briefly washed in PBS/0.05% Tween
20. Monolayers of macrophages or fibroblasts on Permanox
 
®
 
chamber slides (Nalge Nunc International) were washed with
PBS and fixed in acetone without prior air-drying. Nonspecific
binding sites were blocked for 30 min with PBS/0.1% saponin/
1% BSA/20% FCS. Immunoperoxidase staining (with 3-amino-9-
ethyl-carbazole as a substrate), alkaline phosphatase immunoen-
zymatic labeling (with Fast Blue BB salt as a substrate), and hema-
toxylin counterstaining were performed as described previously
(17, 23).
 
Immunofluorescence and Laser Scanning Confocal Microscopy.
 
For
double and triple immunofluorescence, acetone-fixed fibroblast
or macrophage monolayers or cryostat sections were blocked (see
above) and simultaneously incubated (45 min, room temperature)
with two or three different primary antibodies diluted in PBS/
0.1% BSA/0.1% saponin. After washing with PBS/0.05% Tween
20, the fluorochrome (Cy5, DTAF, or LRSC)-conjugated sec-
ondary antibody reagents (diluted in PBS/0.1% BSA/0.1% sapo-
nin) were added sequentially for 30 min each, followed by exten-
sive washing steps in between. In cases where two of the primary
antibodies were derived from the same species, complexes of the
first and secondary antibody were formed and free binding sites of
the secondary antibody were saturated with the respective non-
immune serum (10%, 30 min on ice) before adding the com-
plexes to the sections. The slides were finally mounted with
Mowiol (Hoechst) containing 1,4-diazabicyclo-2,2,2-octane
(DABCO; Sigma-Aldrich) as an antifading reagent. DTAF
(green) was excited at 488 nm and collected using a 515–545-nm
band pass filter. LRSC (red) was excited at 574 nm and collected
with a 590-nm long pass filter. Cy5 (red) was excited at 651 nm
and collected with a 665-nm long pass filter. Nuclei were visual-
ized with the DNA stain TOTO-3 (red; Molecular Probes),
which was excited at 642 nm and collected with a 665-nm long
 
pass filter. The slides were examined with a Leica laser confocal
microscope equipped with an argon/krypton laser (laser lines of
488, 568, and 647 nm) using the Leica TCS NT software
(v1.6.551). For the three-color presentation of the images, the far
red emission of Cy5 or of TOTO-3 was turned into blue.
 
Results
 
Isolation and Phenotypic Characterization of Fibroblasts.
 
Fi-
broblasts were isolated from the skin of naive mice and
from the draining (popliteal) lymph nodes of mice that had
healed a cutaneous infection with L. major (.day 200 after
infection). Three skin fibroblast lines (CHF-1, CHF-2, and
NOSS-1) and two lymph node reticular fibroblast lines
(NOBO-1 and NOBO-3) were established and used for in
vitro experiments at passage numbers ,25. The cells were
determined to be fibroblasts on the following grounds: (a)
characteristic morphology, i.e., formation of monolayers
consisting of cells that assumed a pavement-like and spin-
dle-shaped appearance when confluent (see Fig. 2); (b) se-
rum-dependent growth (data not shown); (c) absence of
markers characteristic for macrophages (F4/80, Mac-1,
BM-8, ER-MP-23), dendritic cells (NLDC-145, MHC
class II), granulocytes (GR-1), T cells (Thy 1.2), B cells
(B220), or endothelial cells (MECA-32) (data not shown);
(d) production of a variety of known matrix proteins (fi-
bronectin, laminin-1, fibulin-2, perlecan, and collagen VI)
during in vitro culture for 1–6 d (Fig. 1, A and B, and data
not shown); (e) positive staining with the rat mAb ER-TR7
(Fig. 1 C, and data not shown), which detects an intracellu-
lar component of mouse reticular fibroblasts but also reacts
with an extracellular connective tissue product that is dif-
ferent from the matrix proteins laminin, fibronectin, types
I–V collagen, heparan sulfate proteoglycan, entactin, and
nidogen (33). RPMs or PEMs, in contrast, were negative
for perlecan, fibulin-2, collagen VI, and ER-TR7 through-
out a culture period of 6 d (Fig. 1, E–M) and showed only
a very weak and transient staining with antilaminin or anti-
fibronectin antiserum (not shown). Thus, ER-TR7, perle-
can, and fibulin-2 (and in some experiments also laminin,
fibronectin, and collagen VI) were used as primary markers
for the detection of fibroblasts in lymph nodes.
Reticular Fibroblasts of Lymph Nodes or Skin Fibroblasts Phago-
cytose L. major Parasites. When skin fibroblast monolay-
ers were continuously incubated with L. major promasti-
gotes at a parasite/cell ratio of 3–5:1, the average infection
rate at 48 h was 17.8 (6 9) and 24.7 (6 12.4)% in unstim-
ulated or cytokine-stimulated cells, respectively (mean 6
SD of three experiments; Fig. 1, A and B). Comparable re-
sults were obtained with lymph node fibroblasts and when
L. major amastigotes were used for infection (Fig. 1, and
data not shown). Most of the infected cells contained one
or two parasites; rarely, three parasites were found within
one cell. Phagocytosis and intracellular localization of pro-
or amastigote L. major was confirmed by transmission elec-
tron microscopy (Fig. 2, D and E). These results demon-
strate that both dermal and reticular fibroblasts are capable
of taking up L. major pro- and amastigotes.2124 Leishmania and Fibroblasts
Figure 1. Expression of fibroblast markers by NOBO-1 cells (reticular fibroblasts isolated from the lymph node of a C57BL/6 mouse at day 239 of in-
fection with L. major; A–D), RPMs (E–H), or thioglycollate-elicited macrophages (J–M). The cells were kept in cultures for 4–6 d and then analyzed for
the expression of fibulin-2 (A, E, and J), perlecan (B, F, and K), or ER-TR7 (C, G, and L) by immunoperoxidase staining and hematoxylin counterstain-
ing. Results similar to those shown for NOBO-1 cells were also obtained with primary skin fibroblasts of C57BL/6 mice (not shown). For control pur-
poses, the primary antibodies were omitted and the cells were incubated with the biotinylated secondary reagent alone followed by streptavidin-peroxi-
dase (D, H, and M). Original magnifications: 31,000.
Figure 2. Uptake of L. major pro- or amastigotes by skin fibroblasts
(NOSS-1, CHF-1) or reticular lymph node fibroblasts (NOBO-1) of
C57BL/6 mice. (A–C) Immunoperoxidase staining of intracellular para-
sites, original magnifications 31,000: (A) NOSS-1 fibroblasts, 24 h after
infection with amastigotes; (B) CHF-1 cells, 48 h after infection with
amastigotes; (C) NOBO-1 cells, 24 h after infection with promastigotes.
(D and E) Detection of intracellular L. major by transmission electron
microscopy: (D) NOBO-1 cells, 20 h after infection with amastigotes.
Bar, 2.1 mM. (E) NOBO-1 cells, 24 h after infection with promasti-
gotes. Bar, 2.1 mM.2125 Bogdan et al.
Fibroblasts Have a Reduced Capacity to Produce NO and to
Kill Leishmania Parasites.  As NOS2-derived NO has been
shown to be indispensable for the control of Leishmania in
phagocytes and in mice (8, 9, 34, 35), we analyzed the pro-
duction of NO by fibroblasts in response to cytokines or
microbial products. IFN-g alone or IFN-g plus TNF were
sufficient to activate resting or inflammatory macrophages
for high production of NO. In contrast, skin or lymph
node fibroblasts required a microbial costimulus such as
LPS (Fig. 3 A) or infection with L. major pro- or amasti-
gotes (Fig. 3 B; see also Fig. 3 D). However, whereas .90%
of infected macrophages stimulated with IFN-g/LPS were
positive for NOS2 protein by immunofluorescence analy-
sis, the expression of NOS2 in L. major–infected and IFN-g/
LPS–stimulated CHF-1 or NOBO-1 fibroblasts was re-
stricted to 33 (6 13) or 55 (6 14)% of the cells, respec-
tively (mean 6 SD of five culture wells from two experi-
ments). Furthermore, in the same experiments, only 34 (6
14) or 62 (6 9)% of the intracellular parasites were local-
ized in NOS2-positive fibroblasts.
In accordance with previous reports (22, 34), stimulation
of amastigote-infected macrophages with IFN-g or IFN-
g/TNF for 48–72 h caused a reduction of the total number
of intracellular parasites by 20- to several hundredfold. In
contrast, the average reduction of intracellular amastigotes
was 1.2 (6 0.2) or 4.0 (6 1.8)-fold in reticular fibroblasts
(NOBO-1) and 2.6 (6 1.1) or 5.65 (6 2.2)-fold in dermal
fibroblasts (CHF-1) after stimulation with IFN-g or IFN-
g/TNF, respectively (mean 6 SEM of three to seven ex-
periments; Fig. 3 C). However, coculture of infected fibro-
blasts with uninfected macrophages that were separated by
a membrane significantly increased the killing of the intra-
cellular amastigotes compared with cultures of fibroblasts
alone (Fig. 3 D).
Reticular Fibroblasts as Host Cells for Persisting Leishmania In
Vivo. Next, we addressed the question whether fibro-
blasts represent (part of) the hitherto undefined NOS2-
negative host cell population that harbors 60–70% of all
parasites persisting in the lymph nodes of clinically cured
mice (17). Initial experiments using immunoperoxidase/al-
Figure 3. NO production and killing of intracellular L. major by RPMs, PEMs, skin fibroblasts (CHF-1), and reticular lymph node fibroblasts
(NOBO-1). (A) Nitrite accumulation at 24 or 48 h of stimulation with IFN-g, IFN-g (20 ng/ml) plus TNF (10 ng/ml), or IFN-g (20 ng/ml) plus LPS
(20 ng/ml) by equal numbers of uninfected macrophages (RPMs, black bars; PEMs, gray bars) or fibroblasts (CHF-1, hatched bars; NOBO-1, white
bars) (mean 6 SEM of three to six experiments). (B) Nitrite accumulation in CHF-1 (hatched bars) and NOBO-1 (white bars) fibroblast cultures in-
fected with L. major parasites and stimulated with IFN-g or IFN-g plus TNF (20 ng/ml each) (mean 6 SD of 7–16 experiments). (C) Killing of intracel-
lular Leishmania by PEMs and CHF-1 infected with a fourfold excess of amastigotes (6-h pulse infection) and cultured with or without IFN-g (20 ng/ml)
for 54 h. The total numbers of cell-associated parasites were determined by limiting dilution analysis (one of four experiments). (D) Killing of L. major
amastigotes by NOBO-1 fibroblasts cultured in the absence or presence of PEMs and stimulated with IFN-g/LPS (20 ng/ml each) with or without
L-N6-iminoethyl-lysine (L-NIL; 1 mM) for 72 h as determined by [3H]thymidine incorporation into Leishmania recovered from host cells after SDS lysis
(one of two experiments).2126 Leishmania and Fibroblasts
kaline phosphatase double labeling revealed parasites closely
associated with the reticular fibroblast marker ER-TR7
(Fig. 4 A) or various matrix proteins (not shown). Subse-
quently, .200 sections of 5 lymph nodes derived from 5
independent time course experiments (day 145–530 after
infection) were analyzed by confocal laser microscopy. In a
first series, 332 L. major amastigotes were analyzed for their
colocalization with NOS2 and extracellular matrix proteins
(fibulin-2, perlecan, laminin, or collagen VI). 256 (77%) of
all parasites were NOS2-negative, confirming our previous
findings (17). 102 of the NOS2-negative Leishmania (i.e.,
30% of the total parasites) were tightly embedded in or
closely surrounded by matrix. Only 8% of the total parasites
colocalized with matrix and NOS2. Similar results were
obtained in a second series of sections, in which 824 L. ma-
jor amastigotes were assessed for their association with the
ER-TR7 marker, NOS2, and host cell nuclei. 549 (66%)
of all parasites were found within NOS2-negative areas, of
which 358 (i.e., 43% of all parasites and 65% of the NOS2-
negative parasites) colocalized with ER-TR7 (Fig. 4 C).
Only 20% of all parasites colocalized with ER-TR7 and
NOS2 (Fig. 4 D). At least 50% of the ER-TR7–positive
amastigotes were located in the close vicinity of host cell
nuclei, which further demonstrates that fibroblasts harbor
Leishmania in vivo (Fig. 4 B). By similar triple immunoflu-
orescence labeling, we found parasites not only within
macrophages (Fig. 4 E) and dendritic cells (not shown), but
also in areas devoid of host cell nuclei and fibroblasts (Fig. 4
F). Thus, fibroblasts are host cells for persisting L. major
along with other cell types, but Leishmania can also be de-
tected in necrotic areas of the chronically infected lymph
nodes.
Figure 4. Association of L. major parasites with fi-
broblasts in popliteal lymph nodes of C57BL/6 mice
during the chronic (latent) phase of infection (A, day
206; B–D and F, day 530; E, day 452). (A) L. major
amastigote (alkaline phosphate staining, blue) tightly
associated with the ER-TR7 fibroblast marker (immu-
noperoxidase staining, brown; original magnification:
31,000). (B–F) Triple immunofluorescence overlay
images obtained by confocal laser microscopy (acquired
with a 403 objective lens, zoom factor 1.0–1.74). (B)
Three L. major parasites (DTAF, green) in a ER-TR7–
positive cell (nucleus, blue [TOTO-3]; ER-TR7
marker, red [LRSC]). The left of these Leishmania di-
rectly colocalizes with the ER-TR7 marker. A fourth
parasite on the right is presumably located in a neigh-
boring cell. (C) Seven to eight L. major parasites
(DTAF, green; arrow) that colocalize with ER-TR7
(LRSC, red) and therefore appear yellow, but are
clearly outside an NOS2-positive area on the bottom
of the image that is stained with Cy5 (blue) and appears
purple due to colocalization with ER-TR7. (D) Nine
L. major parasites (DTAF, green) colocalizing with ER-
TR7 (LRSC, red) and NOS-2 (Cy5, blue), therefore
appearing white. (E) L. major parasites (DTAF, green)
colocalizing with a Mac-1–positive cell (Cy5, blue, ar-
row; two intracellular turquoise parasites) or with ma-
trix (laminin/perlecan-III, LRSC, red; one yellow par-
asite [arrowhead]). (F) Cluster of 10 L. major parasites
(DTAF, green) located in a (presumably) necrotic area
of the lymph node largely devoid of nuclei (TOTO-3,
blue) and fibroblasts (ER-TR7, LRSC, red).2127 Bogdan et al.
Discussion
Fibroblasts as Host Cells for Leishmania. Although mac-
rophages are considered to be the most important host cell
for Leishmania parasites, several other cell types have been
shown to endocytose Leishmania in vitro or in vivo. These
include neutrophils (36–38), eosinophils (39–41), dendritic
cells (42, 43), and epithelial cells (44). Throughout the 20th
century, a possible infection of fibroblasts or fibroblast-like
mesenchymal cells with Leishmania species other than L.
major has been sporadically witnessed by some researchers
in animal models or in (experimentally) infected humans
(45–49). In vitro, several authors demonstrated the uptake
of pro- or amastigotes of L. donovani, L. mexicana amazonen-
sis, and an L. braziliensis–like species by human skin fibro-
blasts (18–20). However, none of the above-mentioned
studies provided any evidence that the infection of fibro-
blasts with Leishmania might be relevant for the survival of
the parasites in vivo; investigated the expression of NOS2
by fibroblasts and analyzed the antileishmanial activity of fi-
broblasts after cytokine stimulation; or determined the ac-
tual frequency of Leishmania residing in professional phago-
cytes versus fibroblasts in vivo. Our present study shows
that the majority of the parasites that are found in NOS2-
negative areas of latently infected lymph nodes and do not
colocalize with known macrophage and dendritic cell
markers (z60–70% of the total parasites [17]) are tightly as-
sociated with reticular fibroblasts. Thus, fibroblasts repre-
sent a hitherto unrecognized important host cell for Leish-
mania persisting in vivo.
Fibroblasts as Safe Targets for Leishmania. Previous re-
ports on the interaction of unstimulated human skin fibro-
blasts with Leishmania species other than L. major provided
evidence that the parasites can persist within these cells in
vitro for prolonged periods of time (3–7 d), although repli-
cation of the parasites did not occur (18–20). Our present
analysis shows that cytokine-stimulated fibroblasts have a
limited capacity to kill intracellular L. major parasites in
vitro. This is not due to a principal inability to produce
NO. However, adherent fibroblasts stimulated with IFN-g
(with or without  TNF-a) released much less NO than
macrophage monolayers, and even after stimulation with
IFN-g plus LPS the expression of NOS2 protein was re-
stricted to 30–50% of the fibroblasts (depending on the cell
line). Similar observations were previously made with em-
bryonic fibroblasts (50). After infection, production of NO
was enhanced but still considerably lower than in macro-
phages. Furthermore, only 35–60% of the parasites were
localized in NOS2-positive fibroblasts. Both factors might
support the survival of L. major parasites within fibroblasts.
Importantly, parasites residing in fibroblasts remained sus-
ceptible to the NO produced by neighboring macrophages
(Fig. 3 D). Thus, macrophage-derived NO is able to con-
trol the Leishmania in nearby NOS2-negative fibroblasts,
which might help to maintain a stable balance of parasite
killing and evasion in the chronically infected lymph nodes.
We considered the possibility that the localization of
Leishmania in fibroblasts might also protect the parasites
against the activity of standard antileishmanial drugs and
thereby account for the persistence of Leishmania after che-
motherapy. When we treated long-term–infected, clini-
cally cured C57BL/6 mice with a combination of pen-
tostam and amphotericin B (Ambisome®), there was a
strong (z900-fold) reduction of the parasite burden. How-
ever, we did not observe an increase in the number of par-
asites associated with fibroblast markers. Thus, to date we
do not have evidence for a preferential survival of L. major
parasites after chemotherapy in fibroblasts.
Extracellular Matrix and Leishmania. Although our con-
focal laser microscopy analysis strongly suggests that L. ma-
jor parasites are located within fibroblasts in vivo (Fig. 4 B),
we cannot exclude that some of the persisting Leishmania
amastigotes are located extracellularly tightly embedded by
matrix (Fig. 4, A and C, and data not shown). In addition,
in the chronically infected lymph nodes, Leishmania
amastigotes were also seen in necrotic areas lacking nucle-
ated cells (Fig. 4 F). In this context, it is important to note
that L. mexicana amastigotes express surface molecules that
were shown to function as ligands for certain (extracellular)
proteoglycans (51). Extracellular amastigotes, surrounded
by connective matrix, have also been seen in acute leish-
manial skin lesions of humans infected with L. braziliensis
guyanensis, but the finding was not discussed (52). Whether
a possible extracellular localization of the parasite in a con-
nective tissue matrix contributes to the control (i.e., killing)
of the parasite or to its long-term survival in the host is un-
known to date.
In conclusion, we have demonstrated that ingestion of
Leishmania by fibroblasts is a frequent event during latent
disease. Our data suggest that fibroblasts might form a less
hostile environment for L. major than macrophages and
thereby allow for the persistence of the parasites. Parasite
survival and replication, however, are subject to control by
neighboring macrophages that are effective against Leish-
mania residing in fibroblasts and thereby help to maintain a
stable host–parasite relationship. Whether such a mecha-
nism also operates in latently infected humans remains to
be established.
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